Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?

Scandinavian Journal of Primary Health Care

Volumn 22, Issue 3, 2004, Pages 187-190

  Schaufelberger, Maria ^a   Bergh, Claes Håkan ^a   Caidahl, Kenneth ^a   Eggertsen, Robert ^a,c   Furenäs, Eva ^a   Lindstedt, Göran ^b   Nilsson, Thomas ^a   Stefferud, Kari ^b   Swedberg, Karl ^a  

^a Molnlycke Prim Hlth Care/Res Ctr   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Mölnlycke Vårdcentral ^*  (Sweden)

Author keywords

BNP; Brain natriuretic peptide; Ejection fraction; Primary care

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; GENERAL PRACTICE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL EXAMINATION; PRIMARY MEDICAL CARE; SYMPTOMATOLOGY;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; FAMILY PRACTICE; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MASS SCREENING; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENT CLINICS, HOSPITAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SWEDEN;

EID: 4644326733     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/02813430410006594     Document Type: Article

References (12)

1. Hobbs R. Can heart failure be diagnosed in primary care? BMJ 2000;321:188-9.
2. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines. Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741-51.
3. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
4. Yamada Y, Goto J, Yokota M. Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease. Cardiology 1997;88:401-7.
5. Yamamoto K, Burnett Jr JC, Bermudez EA, Jougasaki M, Bailey KR, Redfield M. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail 2000;6:194-200.
6. Cowie MR, Struthers AD, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1347-51.
7. McClure SJ, Caruana L, Davie AP, Goldthorp S, McMurray JJ. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ 1998;317:516-9.
8. Landray MJ, Lehman R, Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. BMJ 2000;320:985-6.
9. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21.
10. Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. J Card Fail 2000;6:130-9.
11. Davidson NC, Naas AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal pronatriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996;77:828-31.
12. Smith H, Pickering RM, Struthers A, Simpson I, Mant D. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ 2000;320:906-8.